Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

Abstract Background Among medically ill patients treated with thromboprophylaxis, betrixaban was not associated with an increase in major bleeding compared with enoxaparin, but an increase in clinically relevant non-major (CRNM) bleeding was observed. The aim of this analysis is to desc...

Full description

Bibliographic Details
Main Authors: Megan K. Yee, C. Michael Gibson, Tarek Nafee, Mathieu Kerneis, Yazan Daaboul, Serge Korjian, Gerald Chi, Fahad AlKhalfan, Adrian F. Hernandez, Russell D. Hull, Alexander T. Cohen, Samuel Z. Goldhaber
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2019-04-01
Series:TH Open
Subjects:
venous thromboembolism
betrixaban
acutely ill patients
major bleed
clinically relevant non-major bleeding
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1685496

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1685496

Similar Items